PubMed Health⌕ Search

PubMed · 8234765

Fatigue during functional neuromuscular stimulation.

Abstract

Discontinuous activation of muscle compartments is used to postpone the occurrence of fatigue during both normal activation and artificial stimulation. Periods of force development are interrupted by passive periods during which the muscle can recover. Since it is not known how fatigue parameters depend on intermittent stimulation, we compared fatigue generated by continuous electrical stimulation with fatigue resulting from intermittent stimulation schemes. T5-T6 paraplegics participated in the experiments. Continuous stimulation generated a torque time course that can be described by a rising and a falling exponential time constant. The falling time constant ranged from 100 to 200 sec in all four patients and did not depend on the amplitude of the stimulation pulses. The torque developed at times greater than 250 sec was asymptotically constant and proportional to the maximal torque developed by each patient. Intermittent stimulation appears to postpone fatigue markedly. The torque time course developed in each on/off cycle again was a double exponential. In intermittent stimulation schemes average torque determines the muscle's performance. Therefore, average torque versus time was calculated from the intermittent stimulation data. These relations also follow a double exponential, accurately providing confident estimates of fatigue parameters. Fatigue caused average muscle torque to decline to a constant level which, for each patient, was uncorrelated with the duty cycle of the stimulation pattern. Between patients these levels varied from 18.3 +/- 7.1 to 9.9 +/- 4.3 (% of maximal torque +/- standard error). These findings result in a model that could be of use in controllers for functional neuromuscular stimulation (FNS) that take into account non-stationarity caused by fatigue.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H B Boom, A J Mulder, P H Veltink. 1993. Fatigue during functional neuromuscular stimulation.. https://doi.org/10.1016/s0079-6123(08)62300-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Modeling biological motor control for human locomotion with functional electrical stimulation.

This paper develops a novel control system for functional electrical stimulation (FES) locomotion, which aims to generate normal locomotion for paraplegics via FES. It explores the possibility of applying ideas from biology to engineering. The neural control mechanism of the biological motor system, the central pattern generator, has been adopted in the control system design. Some artificial control techniques such as neural network control, fuzzy logic, control and impedance control are incorporated to refine the control performance. Several types of sensory feedback are integrated to endow this control system with an adaptive ability. A musculoskeletal model with 7 segments and 18 muscles is constructed for the simulation study. Satisfactory simulation results are achieved under this FES control system, which indicates a promising technique for the potential application of FES locomotion in future.

Electric Stimulation Therapy↗

Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience.

OBJECTIVES: With the increasing use of sacral neuromodulation therapy, urologists are faced with postimplantation challenges. The purpose of this study was to identify these events and their causes and management in our large single-institution experience. METHODS: From July 2002 to September 2004, all patients who underwent sacral neuromodulation therapy for refractory bladder conditions were identified. Their medical records were retrospectively evaluated for history, operative intervention, and programming visits. Events after implantation of the implantable pulse generator (IPG) unit were noted. The evaluation, troubleshooting, management, and resolution of events at the last follow-up visit were extracted. RESULTS: A total of 214 patients underwent sacral neuromodulation therapy at our institution. The mean patient age was 53.5 +/- 15.4 years. Of the 214 patients, 161 underwent IPG implantation during a mean follow-up period of 16 months (range 5 to 30). The second-stage explantation and revision rate was 10.5% and 16.1%, respectively. The indications for explantation were infection (8 of 17) and failure to maintain a response (9 of 17). Revisions were done for decreases in response with abnormal (12 of 26) or normal (5 of 26) impedance measurements, IPG site discomfort (4 of 26), draining sinus at the IPG site (4 of 26), and lead migration (1 of 26). Equalization of impedance measurements was the most commonly observed impedance abnormality. These were managed by drying fluid from the connection in 4 patients and lead change in the rest. CONCLUSIONS: After IPG implantation, a decline in response may occur. Although some were explanted, most were revised, with most of the revisions functional on follow-up. Familiarity with impedance evaluation and development of algorithms for postimplant management are essential for troubleshooting and maintenance of the device.

Electric Stimulation Therapy↗